FDA grants RMAT designation to Ocugen's OCU410 for dry AMD
Go back to FDA grants RMAT designation to Ocugen's OCU410 for dry AMD| (NASDAQ: OCGN) | Delayed: 1.23 -0.03 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.26 | 52 Week High | $ | |||
| Open | $1.29 | 52 Week Low | $ | |||
| Day High | $1.30 | P/E | N/A | |||
| Day Low | $1.23 | EPS | $ | |||
| Volume | 4,144,940 | |||||
